chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse refers to a 11 months old patient(gender unspecified). On an unknown date, the patient was vaccinated with a dose of VARIVAX (lot # and route not reported) at 11 months and 7 days of age. No concomitant medications were reported. No adverse effect was reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Fever of about 100 degrees Fahrenheit, sore throat and red spots on hands and feet until 9/18/2015.
The day after getting vaccine I got flu like symptoms headache bodyaches sore arm chills high fever fatigue freezing one minute hot the next I was told to take Tylenol ibprophen
Immense fatigue and brain fog (felt disorganized and unable to follow a familiar recipe), anxiety, loss of appetite, constipation, inability to fall asleep, sweating, unable to concentrate or to work around the house, fatigue after eating
pt recv vax & devel angioedema on the skin creases of the legs; f/u 15NOV94 indicated pt has rxn to chemical in car seat & not the vax;
have it now / I was vaxed/ suspected vaccination failure; I have it now; pain under my right rib; bad back pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rib pain and back pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, rib pain and back pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, rib pain and back pain to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. At the time of reporting, the patient had shingles, but no rash or blisters. The patient experienced bad back pain and pain under right rib after vaccinaation with shingles vaccine. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
is reported as potential AE because of temperature excursion; Initial information received on 08-Mar-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown demographic and unknown gender patient who experienced is reported as potential ae because of temperature excursion while receiving vaccines IPV (VERO) [IPOL] and MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U7211AA and suspect IPV (VERO) lot U7191AB.  On an unknown date the patient developed a non-serious is reported as potential ae because of temperature excursion (product temperature excursion issue) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and (unknown latency) following the administration of IPV (VERO).  It was reported "that she doubts an excursion actually happened and most likely might have been a glitch since it triggered after the data logger was plugged in and the back up data loggers did not record any temperatures out of range. See related case 01009162 for opened IPOL Additional Description of event Adverse events :Nurse is requesting stability information for unopened MENACTRA and opened IPOL after the data logger recorded 30.5 degrees F lasting for 14 minutes".  Action taken:not applicable.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was Unknown.
R hand became cold and turned purplish/ Red color If he shakes the hand around - he gets sensation and normal color back - but once hand is still, the color immediately goes back to the dark color, and cold.  Took to urgent care for medical eval.  By the time he got there it was almost back to normal and was told there was really nothing they could of for them. Told to monitor sx and if returns to be seen in the ER.  Mother administered Benadryl when they got home, improvement shown.  As of this am Hand was back to normal and has had no issues since.
Patient  is a direct admission from ED with chest pain x2 days, dizziness, transient left eye blurry vision this morning and general body weakness. He was managed for: Acute Upper GI Bleed, acute Symptomatic anemia in the setting of Above, Hx of bleeding gastritis and duodenal ulcers, and Hx of  Uncomplicated diverticulosis. Positive COVID-19 infection. Treated for all hospital problems and discharged home. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Admission Date: 4/29/2022 Discharge Date: 4/30/2022 PRESENTING PROBLEM: Dehydration [E86.0] SIRS (systemic inflammatory response syndrome) (HCC) [R65.10] AKI (acute kidney injury) (HCC) [N17.9] COVID-19 virus detected [U07.1]  HOSPITAL COURSE: Admission history:A 90 y.o. male who presented with weakness. pmh htn, bph,ckd 3 .  States wife dx with covid 3 weeks ago and has been required to take care of her . Notes he had uri ss shortly following and was tested for covid at Atrium and told was neg . 4 days ago with onset cough non productive of sputum . Has progressively become increasingly fatigued and generally weak . Notes decreased appetite and po intake though feels has kept up on liquids . Denies fever or chills, n,v, no myalgia,no co diarrhea , melena or hematochezia. Brought wife into ed today due to her sob. While in ed experienced light headedness , became diaphoretic . Bp on eval noted at 60's/40's .  In ed given x3 l ns with improved subjective ss . Lactic level elevated to 2.5 , k elevated to 5.5 . Baseline creat near 1.3 found to be 1.7  on admit . Following infusions felt much improved with resolved light headedness and felt much stronger . For aki was gently hydrated over night , ace i was held. Creat improved to baseline 1.19 . He did test positive for covid 19 however with no pulmonary co or hypoxia . On day of dc was ambulating in halls without assist , bp readings at goal with no orthostatics . He was making good amount of urine , taking oral intake well  And requesting dc. In instructed him to self isolate for 5 more days . He is to call for follow up pcp appointment to be seen following isolation period or with concerns or questions . To resume lisinopril on 5/1/22
pt states her left arm is red, hot and heavy.  She has episodes of the pain and numbness in her fingers that come and go.  When this happens she gets a dry cough and has to clear her throat in order to have air to breath. She has had these symptoms a going on a couple of months now.  Pt will wait for her new insurance to activate before she can schedule an appt with a doctor.
Patient received 3rd dose of Moderna vaccine 8/23/21 at 10:16AM.  Her mother called 8/24/21, stating that she had an adverse reaction to the vaccine and wanted to report it.  Patient was in the background of the call and gave permission for her mother to speak on her behalf.  She states that on 8/24/21 at approximately 3am she experienced sever fever/chills/sweating.  This woke her up and she got out of bed to turn on the air-conditioner and passed-out (fainted) in the hallway.  She was passed-out for 15 minutes and then got up and went back to bed.  At the time of the phone call on 8/24/21 at 3pm, she was experiencing only a mild headache and mild chills.  Patient states that she is taking Mavenclad for Multiple Sclerosis.
Patient received Moderna 1/16/2021 Received Johnson  & Johnson 4/8/2021 Works in high risk job and wanted booster as 10 months out from last shot and Omicron wave.    At her first Moderna vaccine on January 16, 2021, she had facial erythema, odd throat sensation, and flushing 20 minutes into her vaccine prompting extended monitoring but which resolved without medication. Since she was not fully immunized, she was switched to Johnson & Johnson which was administered in our office on 4/8/2021 as a vaccine challenge.  During the challenge with J&J she reported some subjective symptoms of throat tightness and odd skin sensation and was given cetirizine due to a sensation of skin crawling at the 1 hour point and observed for a total of 1.5 hours.  There were no objective findings during the J&J challenge.   She contacted the office in December to ask if she should get a booster when Omicron cases were on the rise in area,  She has been on an atypical dosing schedule with Moderna in January 2021 and J&J in April 2021.  Given there was no data available for this series in this order and timing and it was now 10 months since the last injection, we decided that she should be boosted. Given the concerns there were with Johnson & Johnson adverse events and lack of data regarding protection for Omicron when she scheduled, we opted to booster her with the Pfizer mRNA Sars-CoV-2 vaccine.  On 2/10/22, twenty minutes after Pfizer vaccine, reported numbness/tingling sensations of her right tooth, throat, and scalp.   This was not felt to be an allergic reaction as no concerning changes in vitals signs. No hives. No angioedema. No wheezing.   She called the office on 2/14/22 stating: " As of today, my right forearm is partially numb. In addition to that, I have had intermittent head pain and I don't get headaches. I have also had an intermittent dry cough and occasional upper right chest heaviness. The numbness in my face actually moves around the right side of my head and face and comes and goes. It's been like this all week.  The Chest heaviness has been minimal, but later yesterday afternoon, it was very noticeable. Other than a little chest heaviness on the right side this morning, it has since stopped. It comes and goes though. All of these things are coming and going and the face and head numbness seems to be following a nerve."
I63.89 SUPERIOR CEREBELLAR ARTERY SYNDROME 4/13/2023 DIZZINESS I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 3/29/2023 DIZZINESS
Large red spot (maybe 4 inches long and 3 inches wide) and itchiness; red spot feels a little hot.
Patient came in for fluvarix vaccine, but vaccinator made an administration error and gave pediatric Pfizer (age 5-11) vaccine. Mother is already fully vaccinated for covid, including booster. Mother held for 30 minute observation, no Fluvarix given. I followed up with mother after speaking with Infectious Disease Doctor. I relayed the information given to me and checked on how she was doing. She said she felt fine and was having no issues.
Sweats and fussiness the evening following the immunization administration.  Localized swelling (~1cm), erythema and tenderness at injection site.
Swollen arm pain going all the way down to hand fluid at elbow and forearm Dr said needle hit nerve in arm
losing smell and taste; body aches; fatigue; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (losing smell and taste), PAIN (body aches), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN (body aches), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills). On 23-Jan-2021, the patient experienced ANOSMIA (losing smell and taste). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ANOSMIA (losing smell and taste), PAIN (body aches), FATIGUE (fatigue), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Tired, headache beginning 24 hours after vaccine. Continued and became more severe approx. 48 hrs. later.  Cough developed * dizziness approx. 18 hrs. after vaccine.
Child was given vaccine diluent without the addition of the dry powder medication component. The practitioner mistakenly forgot to mix the drug and diluent prior to administration. The error was noted and the child was subsequently vaccinated with the correct mixture.
Immediate after I received the booster on my left arm, tingling started on my left hand finger tips. Then spread to my left hand, arm, right hand and arm. Tingling became numbness in both hands and arms. Followed by rapid heartbeat. The on-site nurse checked my pulse and was 106. Nurse gave me some juice and snacks. The rapid heartbeat lasted about a few minutes. The tingling and numbness lasted about an hour and a half. No treatment was given at the vaccine site and went home. At night time, around 9:20pm, intermitent tingling started in my upper lip. By Friday night, the tingling in the upper lip resolved, but followed by fever and chills, took some Tylenol and symptoms went away. Saturday and Sunday experienced intermittent numbness, pin and needle feeling in left hand and lower arm.
Site: Pain at Injection Site-Mild, Systemic: Patient complains about not being able to lift his arm.-Mild, Additional Details: Patient came to the pharmacy complaining about not being able to lift his arm days after getting the flu shot. He specifically said vaccine was given on his deltoid at the correct site, injection site was clean. Patient did not have any visible bruising, inflammation, redness or allergic reaction. When I administered the vaccine I avoided any tattoes and injected the flu shot at a 90 degree angle, around the center and thickest portion of the deltoid muscle, around 3 fingers below the acromion.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 41 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing), notes: Known allergies: Sulfa. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. It was unknown if the patient had received any other medication in 2weeks. Patient had received unspecified medication as a treatment of COVID-19 from 11Jul2022 to 15Jul2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Developed rash on right index finger and dramatic itching of throat and mouth. Onset was sudden approximately 7 hours post vaccine. Immediately took 2 generic Benadryl tablets (25 mg each). Within 30 minutes, throat/mouth itching resolved and rash on finger itched less. Rash on finger resolved within 1.5 days.
Extreme itching at sight very inflamed hot to the touch red area covering entire bicep.  Loss of appetite pain and congestion provided child with Motrin and Benadryl reported symptoms to doctor monitoring reaction.
This spontaneous report was received from a physician concerning his daughter of unknown age. On an unknown date, sometime in the mid to late 90's the patient was vaccinated with a dose of (Merck) VARIVAX (route, lot number and expiration date were not provided). Physician reported that his daughter experienced blister at the injection site sometime in the mid to late 90's. The patient had since recovered also sometime in the mid to late 90's. She did not seek medical attention. Additional information has been requested.
This spontaneous report was received from a nurse via a company representative, and refers to a 11 year old female patient. The patient's concurrent conditions included "heavy menstrual flow".  The patient's pertinent medical history, drug reactions or allergies were not reported. On "May 14th or 15th" 2018, the patient was vaccinated in the doctor's office with GARDASIL 9 (dose, route, lot number and expiration date were not reported) and with MENACTRA (dose, route, lot number and expiration date were not reported) for "11 years old vaccination to enter 7th grade". On the same day, after vaccination, the patient fainted. After resting a short while, the patient left the office. The patient received an unspecified treatment for the event. No further adverse effect reported. The causal assessment between the event syncope and the suspect therapies was not provided.
03/01/2006 Appeared with lesions that were dx varicella > 50 pox
CLIENT RECEIVED ONLY THE "MenCYW" COMPONENT OF THE VACCINE. THE MenA COMPONENT WAS NOT DILUTED AND NOT ADMINISTERED.
Patient was hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was stenosis of left carotid artery.
High pitch cry, fever and irritability 12-24 hr after vaccines. Admitted to hospital to r/o sepsis. Doing better the next day. Possible discharge after 48 hr.
no adverse effects; improperly stord dose of VAQTA; This spontaneous report was received from a medical assistant concerning to a 7-year-old female patient. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  On 03-OCT-2019, the patient was vaccinated with an improperly stored dose of Hepatitis A Vaccine, Inactivated (VAQTA) lot number S005725 with expiration date on 07-OCT-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion of 46.5 degrees Fahrenheit (F) for 5 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.
11/3/2022 I woke up with a sore throat, a mild cough and a stuffy nose. I did an at home COVID test and it was positive. I called my doctor and requested PAXLOVID and it was prescribed. I began taking it that evening. It altered my taste buds, but I responded very well. My follow up COVID test 3 days after 1st test, it was positive. Two days after I completed my PAXLOVID, my at home COVID test was negative. I felt fine throughout the course of taking my medicine. I have fully recovered.
NUMBNESS OF TWO FINGERS AND THE RIBS OF THE PALM ON THE LEFT ARM; REDNESS HAS FORMED ON THE BEND OF THE ELBOW; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 01-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-JUL-2021, the subject experienced numbness of two fingers and the ribs of the palm on the left arm. On 07-JUL-2021, the subject experienced redness has formed on the bend of the elbow. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from numbness of two fingers and the ribs of the palm on the left arm, and had not recovered from redness has formed on the bend of the elbow. This report was non-serious.
Rash; Vaccine first dose administered subcutaneously; A spontaneous report  was received from a consumer, 34 years-old female patient, unknown race and ethnicity, who received Moderna's COVID-19 vaccine (mRNA-1273), and experienced rash and "vaccine first dose administered subcutaneously".  The patient's medical history was not provided. No concomitant medications were reported.  On 07 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (batch number: 026L20A), subcutaneously in the left arm for the prophylaxis of COVID-19 infection.  On 07 Jan 2021, the patient received her first dose which pulled up the fat on the back of her left arm and administered the vaccine subcutaneously. On 14 Jan 2021, one week after the first dose, the patient experienced rash and went away on an unknown date in 2021.   On 04 Feb 2021, the patient received the second planned dose of mRNA-1273 (batch number: 030L20A), intramuscularly for the prophylaxis of COVID-19 infection. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event rash was resolved on an unknown date in 2021 and "vaccine first dose administered subcutaneously", was considered as resolved on 07 Jan 2021.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 and concerns a 34 year-old, female patient, who experienced the event of rash. The event occurred 1 week after the first dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start of the event, a causal relationship cannot be excluded and the event is assessed as possibly related.
Fever (101), mild chills, moderate soreness at injection site. TYLENOL, 2-days.
Patient was given Tenanus and Diphtheria on April 9, 2004.  After a week,noticed that pain was increasing. Also states that she felt a burning sensation running up and down her arm as well as numbness and cold finger tips.    Made appointment with doctor.  Was seen on April 19, 2004.  By this time, pain began to feel very sore but numbness and cold fingertips remain.  Also mentions that she feels as if she has a hole on her arm.  Patient states doctor told her that the pain on arm is not related to vaccine.  Patient also stated to doctor that she has never felt this way before.  Doctor gave no treatment and asked her to come back in a month.  Patient continues to feels a hole, numbness and cold finger tips. Patient has trouble lifting objects such as; holding a cup of water, grocery bags, household chores, and reaching for itmes.  Has also had to stop work because of the pain.  Patient has also had problems sleeing.  Her next appointment is scheduled for June 1, 2004.
Temp elevation began 2 hrs. after immun.(no thermometer) Temp decreased with tylenol but reoccured until 48 hrs after shot and red, blotchy rash began on face, spread over next few days to torso, genitals, and limbs. Recommended Mo. take to MD for eval. Child eating and sleeping well.
Felt pain in left arm immediately followed by difficulty breathing, sweating, nausea,  loss of hearing and vision. No treatment given. Suddenly felt ok after a few moments. Went home, got full body aches, chills, tiredness, inability to sleep, and diarrhea
pt mom states started w/fever on 21JUN96 102-104 resolved 25JUN96 but rash started 25JUN96 red-bumpy (?) itchy, restless, cranky;gave DPH it helped rash on trunk of body & face & behind ears;
I tested positive for COVID-19 on February 12, 2022 My symptoms were aching, nausea, stomach pain, loss of taste and smell.
Developed fever 12 hours after vaccination, then significant bodyaches all over 24 hours later.  Fever resolved after 48 hours, but bodyaches still persisting after 48 hours.